Abstract:In studying the binding of host antibodies to the surface antigens of pathogens, the structural and functional characterization of antibody-antigen complexes by X-ray crystallography and binding assay is important. However, the characterization requires experiments that are typically time consuming and expensive: thus, many antibody-antigen complexes are under-characterized. For vaccine development and disease surveillance, it is often vital to assess the impact of amino acid substitutions on antibody binding. For example, are there antibody substitutions capable of improving binding without a loss of breadth, or antigen substitutions that lead to antigenic escape? The questions cannot be answered reliably from sequence variation alone, exhaustive substitution assays are usually impractical, and alanine scans provide at best an incomplete identification of the critical residue-residue interactions. Here, we show that, given an initial structure of an antibody bound to an antigen, molecular dynamics simulations using the energy method molecular mechanics with Generalized Born surface area (MM/GBSA) can model the impact of single amino acid substitutions on antibody-antigen binding energy. We apply the technique to three broad-spectrum antibodies to influenza A hemagglutinin and examine both previously characterized and novel variant strains observed in the human population that may give rise to antigenic escape. We find that in some cases the impact of a substitution is local, while in others it causes a reorientation of the antibody with wide-ranging impact on residue-residue interactions: this explains, in part, why the change in chemical properties of a residue can be, on its own, a poor predictor of overall change in binding energy. Our estimates are in good agreement with experimental results-indeed, they approximate the degree of agreement between different experimental techniques. Simulations were performed on commodity computer hardware; hence, this approach has the potential to be widely adopted by those undertaking infectious disease research. Novel aspects of this research include the application of MM/GBSA to investigate binding between broadly binding antibodies and a viral glycoprotein; the development of an approach for visualizing substrate-ligand interactions; and the use of experimental assay data to rescale our predictions, allowing us to make inferences about absolute, as well as relative, changes in binding energy.

Identification of Strategic Residues at the Interface of Antigen–Antibody Interactions by in Silico Mutagenesis

In Silico Methods In Antibody Design

Calculation of Relative Binding Free Energy for Mutations in Protein Complexes: The Alchemical Path

In silico design of high-affinity antigenic peptides for HLA-B44

Improving Antibody Affinity Through in Vitro Mutagenesis in Complementarity Determining Regions

A mutagenesis study of autoantigen optimization for potential

An Efficient Approach to the Accurate Prediction of Mutational Effects in Antigen Binding to the MHC1

Development and experimental validation of computational methods for human antibody affinity enhancement

Toward enhancement of antibody thermostability and affinity by computational design in the absence of antigen

Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based in silico approaches

Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction

TransMut: a Program to Predict HLA-I Peptide Binding and Optimize Mutated Peptides for Vaccine Design by the Transformer-derived Self-Attention Model

<i>In Silico</i> Immunogenicity Assessment of Therapeutic Peptides

In Silico Antibody Mutagenesis for Optimizing Its Binding to Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2

Site-Mutation of Hydrophobic Core Residues Synchronically Poise Super Interleukin 2 for Signaling: Identifying Distant Structural Effects Through Affordable Computations

Investigating Substitutions in Antibody–Antigen Complexes Using Molecular Dynamics: A Case Study with Broad-spectrum, Influenza A Antibodies

Design of Nanobody-based Bispecific Constructs by in silico Affinity Maturation and Umbrella Sampling Simulations

Computational Mutagenesis of Antibody Fragments: Disentangling Side Chains from ΔΔ G Predictions

Identifying the Epitope Regions of Therapeutic Antibodies Based on Structure Descriptors

In Silico Immunogenicity Assessment of Therapeutic Peptides

Locuaz: an in-silico platform for antibody fragments optimization